Clinical Trial Update: Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study evaluating the long-term safety and efficacy of galantamine in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED